| abstract |
The present invention is useful as an antagonist of CGRP receptors and is useful in the treatment or prevention of diseases associated with CGRP, such as headache, migraine and cluster headache, Formula I: Formula I: I and Formula II ( In which the variables R 1 , R 2 , R 3 , R 4 , A, B, J, Q, T, V, W, X and Y are as defined herein. About. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved. |